Cargando…
Should timing be considered before abandoning convalescent plasma in covid-19? Results from the Turkish experience
INTRODUCTIONS: Results with convalescent plasma therapy in coronavirus disease 2019 (COVID-19) have been contradictory. Timing seems to be an important factor for COVID-19 convalescent plasma(CCP) to be effective. Aim of this study is to compare disease outcomes in hospitalized COVID-19 patients who...
Autores principales: | Ateş, İhsan, Erden, Abdulsamet, Güven, Serdar Can, Gürler, Elif Kübra, Çağlayan, Adem, Güçbey, Özge, Apaydın, Hakan, Şahiner, Enes Seyda, Küçük, Hamit, Varan, Özkan, Omma, Ahmet, Küçükşahin, Orhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353966/ https://www.ncbi.nlm.nih.gov/pubmed/34412949 http://dx.doi.org/10.1016/j.transci.2021.103238 |
Ejemplares similares
-
Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study
por: Omma, Ahmet, et al.
Publicado: (2021) -
A single center experience of intravenous immunoglobulin treatment in Covid-19
por: Omma, Ahmet, et al.
Publicado: (2021) -
Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19
por: Güven, Serdar Can, et al.
Publicado: (2022) -
COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?
por: Özdemir, Bahar, et al.
Publicado: (2021) -
Correction to: COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?
por: Özdemir, Bahar, et al.
Publicado: (2021)